A61K 47/643
Albumins
Official title: {Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]}
A61K47/643 (Albumins) appears on 687 US grants and 1,230 published applications in this corpus.
Search patents in A61K- Granted patents
- 687
- Published applications
- 1,230
- Assignees
- 567
- Inventors
- 2,113
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 4 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 4 | 0 |
| 1993 | 6 | 0 |
| 1994 | 7 | 0 |
| 1995 | 7 | 0 |
| 1996 | 5 | 0 |
| 1997 | 8 | 0 |
| 1998 | 3 | 0 |
| 1999 | 8 | 0 |
| 2000 | 1 | 0 |
| 2001 | 11 | 3 |
| 2002 | 2 | 15 |
| 2003 | 5 | 22 |
| 2004 | 11 | 22 |
| 2005 | 9 | 15 |
| 2006 | 13 | 26 |
| 2007 | 8 | 21 |
| 2008 | 9 | 32 |
| 2009 | 9 | 29 |
| 2010 | 14 | 36 |
| 2011 | 13 | 33 |
| 2012 | 15 | 48 |
| 2013 | 26 | 43 |
| 2014 | 26 | 58 |
| 2015 | 40 | 70 |
| 2016 | 43 | 84 |
| 2017 | 50 | 78 |
| 2018 | 36 | 69 |
| 2019 | 49 | 66 |
| 2020 | 52 | 67 |
| 2021 | 41 | 69 |
| 2022 | 35 | 72 |
| 2023 | 38 | 76 |
| 2024 | 30 | 76 |
| 2025 | 29 | 64 |
| 2026 | 16 | 36 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Devices, methods, and compositions for thermal acceleration and drug delivery11 Aug 2026US 12,702,478 B2Brown University
- Albumin-proaerolysin prodrugs28 Jul 2026US 12,691,158 B2The Johns Hopkins University
- Therapeutic use of P75NTR neurotrophin binding protein14 Jul 2026US 12,679,880 B2Levicept LTD
- Methods and compositions for treating cancer with cancer-targeted adjuvants7 Jul 2026US 12,673,113 B2The University of Chicago
- Lipoprotein-mimicking solid lipid nanoparticles for drug delivery and uses thereof23 Jun 2026US 12,662,673 B2Tionlab Therapeutics
- Transferrin receptor binding molecule conjugates for delivery of oligonucleotides to cells17 Sep 2026US 2026/0274997 A1Denali Therapeutics Inc.
- Ruthenium (II) Complexes and Conjugates Thereof for Use as Photosensitizer Agent in Photodynamic Therapy3 Sep 2026US 2026/0256916 A1Ecole Nationale Superieure de Chimie de Paris
- Pharmaceutical composition comprising anti-ctla4-anti-pd-1 bispecific antibody and use thereof27 Aug 2026US 2026/0250389 A1Akeso Pharma Co., Ltd.
- Compositions and Methods for Treating Fentanyl Dependence20 Aug 2026US 2026/0240972 A1
- Albumin conjugate, method for producing same, and composition for targeting, diagnosing, or treating cancer comprising same13 Aug 2026US 2026/0232821 A1Ewha University-Industry Collaboration Foundation
Most cited
By later US patents
- Periodic constriction of vessels to treat ischemic tissue245US 6,544,543 B1Advanced Cardiovascular Systems, Inc. · 2003
- Fusion polypeptides comprising human serum albumin, nucleic acids encoding same, and recombinant expression thereof208US 5,876,969 A1999
- Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides138US 5,672,659 AKinerton Limited · 1997
- Fusion polypeptides of human serum albumin and a therapeutically active polypeptide136US 6,686,179 B2Aventis Behring GmbH · 2004
- Combinations and modes of administration of therapeutic agents and combination therapy131US 8,034,375 B2Abraxis BioScience, LLC · 2011